Bridgefront Capital’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Buy
+11,119
New +$242K 0.08% 362
2026
Q1
Sell
-14,142
Closed -$266K 549
2025
Q4
$266K Buy
+14,142
New +$237K 0.07% 398
2025
Q2
Sell
-13,628
Closed -$242K 634
2025
Q1
$242K Buy
+13,628
New +$294K 0.07% 455
2023
Q4
Sell
-11,119
Closed -$77.8K 395
2023
Q3
$77.8K Buy
+11,119
New +$103K 0.05% 367
2021
Q1
Sell
-5,170
Closed -$375K 700
2020
Q4
$375K Buy
+5,170
New +$300K 0.13% 293

Other funds holding CDNA

Bridgefront Capital's CDNA Position: Q2 2026 in Review

Bridgefront Capital opened a new position in CareDx (CDNA) in Q2 2026: 11,119 shares worth $317K. The stake represents 0.08% of the portfolio and ranks #362 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in CDNA as recently as Q4 2025.

Bridgefront Capital first reported a position in CDNA in Q4 2020 and has held it in 5 quarters since. The position peaked at $375K in Q4 2020. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Bridgefront Capital held 11,119 shares of CareDx worth $317K as of Q2 2026.
  • CareDx was a new Bridgefront Capital position in Q2 2026.
  • CareDx made up 0.08% of Bridgefront Capital's portfolio in Q2 2026, its #362 holding.
  • Bridgefront Capital first reported a position in CareDx in Q4 2020 and has held it in 5 quarters since.
  • Bridgefront Capital's CareDx position peaked at $375K in Q4 2020.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.